Therefore, EBI3-inducing DNMTi alone or, especially, in combination with HDACi, such as SAHA, might represent a therapeutic option in inflammatory diseases like colitis to alleviate symptoms and prevent colitis-associated cancer development. Here, EBI3 is linked to colitis.